Edit Content

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Protein Therapeutics Market to reach USD 563.20 billion by the end of 2030

Global Protein Therapeutics Market Size Study & Forecast, by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Follicle Stimulating Hormone), By Application (Metabolic Disorders, Immunologic Disorders, Cancer, Hormonal Disorders, Genetic Disorders, Others), and Regional Analysis, 2023-2030

Product Code: HLSDT-80810322
Publish Date: 20-10-2023
Page: 200

Global Protein Therapeutics Market is valued at approximately USD 325.35 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 7.1% over the forecast period 2023-2030. Protein therapeutics refers to a class of therapeutic agents that are based on proteins or peptides. Proteins are substantial molecules that are crucial for a variety of biological functions, such as immune function, metabolism, and cell signaling. These therapeutic compounds are intended to treat illnesses, disorders, or medical conditions by interacting with certain bodily targets, such as receptors, enzymes, or signaling molecules. The favorable regulatory environment, increase in the geriatric population, and development of the biologics sector, coupled with the rise in healthcare expenditure are the key factors that are spurring the market demand across the globe.

Additionally, the rising prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disorders, and autoimmune diseases is propelling the demand for protein therapeutics during the estimated period. According to National Cancer Institute, in 2018, the number of cancer patients is estimated to account for 18.1 million, which is projected to reach 29.5 million patients by the year 2040. Moreover, the International Diabetic Federation (IDF) reported that in 2021 approximately 537 million adults (20-79 years) are living with diabetes. Also, the total number of people living with diabetes is expected to increase to 643 million by 2030 and 783 million by 2045. Thus, these conditions generally require targeted and personalized treatment approaches like protein therapeutics, which, in turn, augment the market growth at a considerable rate. Furthermore, the rising advancements in biotechnology and protein engineering, as well as the growth in proteomic research present various lucrative opportunities over the forecasting years. However, the high production costs required and the complex manufacturing processes are challenging the market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Protein Therapeutics Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the increasing advancements in biotechnology, growing funding for research and development activities, along with the presence of key players in the region. Whereas, Asia Pacific is expected to grow at the highest CAGR over the forecasting years. The rapidly growing geriatric population, increasing patient awareness toward protein therapeutics, as well as rising prevalence of chronic diseases are significantly propelling the market demand across the region.

Major market players included in this report are:
Novo Nordisk AS
Baxter International Inc.
Amgen Inc.
Merck and Co., Inc.
Sanofi S.A.
Eli Lilly And Company
Abbott Laboratories
Pfizer Inc.
Johnson and Johnson (Janssen Pharmaceuticals)
F. Hoffmann La Roche Ltd

Recent Developments in the Market:
Ø In December 2022, Enlaza Therapeutics announced the introduction with USD 61 million in financing with the objective of advancing the company’s first covalent biologic therapeutic platform. The company integrated novel innovations that allow the introduction of proprietary unnatural amino acids to protein drugs, which allows specific covalent binding to their target proteins.
Global Protein Therapeutics Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered – Product, Application, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Monoclonal Antibodies
Fusion Protein
Human Growth Hormone
Follicle Stimulating Hormone

By Application:
Metabolic Disorders
Immunologic Disorders
Hormonal Disorders
Genetic Disorders
By Region:

North America


Asia Pacific
South Korea

Latin America

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Protein Therapeutics Market, by Region, 2020-2030 (USD Billion)
1.2.2. Protein Therapeutics Market, by Product, 2020-2030 (USD Billion)
1.2.3. Protein Therapeutics Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Protein Therapeutics Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Protein Therapeutics Market Dynamics
3.1. Protein Therapeutics Market Impact Analysis (2020-2030)
3.1.1. Market Drivers Development of the biologics sector Rising prevalence of chronic diseases
3.1.2. Market Challenges High production costs required Complex manufacturing processes
3.1.3. Market Opportunities Rising advancements in biotechnology and protein engineering Growth in proteomic research
Chapter 4. Global Protein Therapeutics Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Protein Therapeutics Market, by Product
5.1. Market Snapshot
5.2. Global Protein Therapeutics Market by Product, Performance – Potential Analysis
5.3. Global Protein Therapeutics Market Estimates & Forecasts by Product 2020-2030 (USD Billion)
5.4. Protein Therapeutics Market, Sub Segment Analysis
5.4.1. Monoclonal Antibodies
5.4.2. Insulin
5.4.3. Fusion Protein
5.4.4. Erythropoietin
5.4.5. Interferon
5.4.6. Human Growth Hormone
5.4.7. Follicle Stimulating Hormone
Chapter 6. Global Protein Therapeutics Market, by Application
6.1. Market Snapshot
6.2. Global Protein Therapeutics Market by Application, Performance – Potential Analysis
6.3. Global Protein Therapeutics Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
6.4. Protein Therapeutics Market, Sub Segment Analysis
6.4.1. Metabolic Disorders
6.4.2. Immunologic Disorders
6.4.3. Cancer
6.4.4. Hormonal Disorders
6.4.5. Genetic Disorders
6.4.6. Others
Chapter 7. Global Protein Therapeutics Market, Regional Analysis
7.1. Top Leading Countries
7.2. Top Emerging Countries
7.3. Protein Therapeutics Market, Regional Market Snapshot
7.4. North America Protein Therapeutics Market
7.4.1. U.S. Protein Therapeutics Market Product breakdown estimates & forecasts, 2020-2030 Application breakdown estimates & forecasts, 2020-2030
7.4.2. Canada Protein Therapeutics Market
7.5. Europe Protein Therapeutics Market Snapshot
7.5.1. U.K. Protein Therapeutics Market
7.5.2. Germany Protein Therapeutics Market
7.5.3. France Protein Therapeutics Market
7.5.4. Spain Protein Therapeutics Market
7.5.5. Italy Protein Therapeutics Market
7.5.6. Rest of Europe Protein Therapeutics Market
7.6. Asia-Pacific Protein Therapeutics Market Snapshot
7.6.1. China Protein Therapeutics Market
7.6.2. India Protein Therapeutics Market
7.6.3. Japan Protein Therapeutics Market
7.6.4. Australia Protein Therapeutics Market
7.6.5. South Korea Protein Therapeutics Market
7.6.6. Rest of Asia Pacific Protein Therapeutics Market
7.7. Latin America Protein Therapeutics Market Snapshot
7.7.1. Brazil Protein Therapeutics Market
7.7.2. Mexico Protein Therapeutics Market
7.8. Middle East & Africa Protein Therapeutics Market
7.8.1. Saudi Arabia Protein Therapeutics Market
7.8.2. South Africa Protein Therapeutics Market
7.8.3. Rest of Middle East & Africa Protein Therapeutics Market

Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. Novo Nordisk AS Key Information Overview Financial (Subject to Data Availability) Product Summary Recent Developments
8.3.2. Baxter International Inc.
8.3.3. Amgen Inc.
8.3.4. Merck and Co., Inc.
8.3.5. Sanofi S.A.
8.3.6. Eli Lilly And Company
8.3.7. Abbott Laboratories
8.3.8. Pfizer Inc.
8.3.9. Johnson and Johnson (Janssen Pharmaceuticals)
8.3.10. F. Hoffmann La Roche Ltd
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com


Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now